1. Home
  2. HTCR vs BIVI Comparison

HTCR vs BIVI Comparison

Compare HTCR & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTCR
  • BIVI
  • Stock Information
  • Founded
  • HTCR 2009
  • BIVI 2013
  • Country
  • HTCR Japan
  • BIVI United States
  • Employees
  • HTCR N/A
  • BIVI N/A
  • Industry
  • HTCR EDP Services
  • BIVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTCR Technology
  • BIVI Health Care
  • Exchange
  • HTCR Nasdaq
  • BIVI Nasdaq
  • Market Cap
  • HTCR 13.6M
  • BIVI 15.1M
  • IPO Year
  • HTCR 2022
  • BIVI N/A
  • Fundamental
  • Price
  • HTCR $0.60
  • BIVI $1.16
  • Analyst Decision
  • HTCR
  • BIVI Strong Buy
  • Analyst Count
  • HTCR 0
  • BIVI 1
  • Target Price
  • HTCR N/A
  • BIVI $30.00
  • AVG Volume (30 Days)
  • HTCR 45.3K
  • BIVI 757.2K
  • Earning Date
  • HTCR 05-20-2025
  • BIVI 05-13-2025
  • Dividend Yield
  • HTCR 3.51%
  • BIVI N/A
  • EPS Growth
  • HTCR N/A
  • BIVI N/A
  • EPS
  • HTCR N/A
  • BIVI N/A
  • Revenue
  • HTCR $30,407,229.00
  • BIVI N/A
  • Revenue This Year
  • HTCR N/A
  • BIVI N/A
  • Revenue Next Year
  • HTCR N/A
  • BIVI N/A
  • P/E Ratio
  • HTCR N/A
  • BIVI N/A
  • Revenue Growth
  • HTCR 39.19
  • BIVI N/A
  • 52 Week Low
  • HTCR $0.52
  • BIVI $0.62
  • 52 Week High
  • HTCR $3.38
  • BIVI $7.50
  • Technical
  • Relative Strength Index (RSI)
  • HTCR 36.41
  • BIVI 59.89
  • Support Level
  • HTCR $0.53
  • BIVI $1.04
  • Resistance Level
  • HTCR $0.61
  • BIVI $1.29
  • Average True Range (ATR)
  • HTCR 0.04
  • BIVI 0.13
  • MACD
  • HTCR 0.01
  • BIVI 0.05
  • Stochastic Oscillator
  • HTCR 33.77
  • BIVI 74.50

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: